Predictors of remission during acute treatment of first‐episode schizophrenia patients involuntarily hospitalized and treated with algorithm‐based pharmacotherapy: Secondary analysis of an observational study

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Early Intervention in Psychiatry

• Publication date

  2019-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/eip.12531PMID 29498481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Algorithm‐based pharmacotherapy for first‐episode schizophrenia involuntarily hospitalized: A retrospective analysis of real‐world practice

  2019cited by this paper
• Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia

  2017cited by this paper
• Duration of untreated psychosis and acute remission of negative symptoms in a South American first‐episode psychosis cohort

  2017influential reference
• 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis and meta-regression of efficacy predictors

  2017cited by this paper
• Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis

  2017cited by this paper
• Managing Negative Symptoms of Schizophrenia: How Far Have We Come?

  2017cited by this paper
• The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.

  2016cited by this paper
• Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

  2016cited by this paper
• The SWITCH study: rationale and design of the trial

  2016cited by this paper
• Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.

  2016cited by this paper
• Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.

  2016cited by this paper
• Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.

  2016cited by this paper
• The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components.

  2015cited by this paper
• Duration of Untreated Psychosis in Community Treatment Settings in the United States.

  2015cited by this paper
• Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.

  2015cited by this paper
• Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.

  2015cited by this paper
• The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.

  2015cited by this paper
• Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis

  2014cited by this paper
• Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.

  2014cited by this paper
• Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.

  2014cited by this paper
• The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.

  2014influential reference
• Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study.

  2014cited by this paper
• Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services

  2013cited by this paper
• Pharmacological approaches to treating negative symptoms: a review of clinical trials.

  2013cited by this paper
• Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.

  2013cited by this paper
• Systematic meta‐analysis of the risk factors for deliberate self‐harm before and after treatment for first‐episode psychosis

  2013cited by this paper
• Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome.

  2012cited by this paper
• Symptomatic and functional remission in patients with first‐episode psychosis

  2012cited by this paper
• Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: A 3-year follow-up study

  2012cited by this paper
• Remission in Schizophrenia: Critical and Systematic Review

  2012cited by this paper
• Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol

  2012cited by this paper
• Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study

  2012cited by this paper
• Remission after first-episode schizophrenia: results of a long-term follow-up.

  2011cited by this paper
• An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.

  2011cited by this paper
• Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years

  2011cited by this paper
• Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?

  2011cited by this paper
• The concepts of remission and recovery in schizophrenia

  2011cited by this paper
• Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.

  2011cited by this paper
• Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

  2011cited by this paper
• Early identification of non‐remission in first‐episode psychosis in a two‐year outcome study

  2010cited by this paper
• An early improvement threshold to predict response and remission in first-episode schizophrenia

  2010cited by this paper
• Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

  2010cited by this paper
• Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

  2010cited by this paper
• International consensus study of antipsychotic dosing.

  2010cited by this paper
• Association between symptomatic remission and functional outcome in first-episode schizophrenia.

  2009cited by this paper
• A multi‐site Canadian perspective: examining the functional outcome from first‐episode psychosis

  2009cited by this paper
• Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).

  2009cited by this paper
• Symptom remission in first episode patients.

  2008cited by this paper
• Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

  2007cited by this paper
• Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.

  2007cited by this paper
• The key to reducing duration of untreated first psychosis: information campaigns.

  2007cited by this paper
• Early detection of the first episode of schizophrenia and suicidal behavior.

  2006cited by this paper
• Premorbid functioning and treatment response in recent-onset schizophrenia

  2006cited by this paper
• Remission in schizophrenia: proposed criteria and rationale for consensus.

  2005cited by this paper
• Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.

  2005cited by this paper
• Early intervention and recovery for young people with early psychosis: consensus statement

  2005cited by this paper
• Meta-analysis of the brief psychiatric rating scale factor structure.

  2005influential reference
• A Brief Mental Health Outcome Scale

  1995cited by this paper
• Anchoring the BPRS: an aid to improved reliability.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• Effectiveness Of Psychoeducation And Assertive Training (PEAT) Combined For Improving Medication Adherence In Patients With Schizophrenia

  2024cites this paper
• Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates

  2024cites this paper
• Evaluation of Serum Complement Levels and Factors Affecting Treatment Resistance in Patients with Schizophrenia

  2023cites this paper
• Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis

  2021cites this paper
• Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review

  2019cites this paper
• Antipsychotika

  2019cites this paper